GTBP logo

GT Biopharma (GTBP) Company Overview

Profile

Full Name:

GT Biopharma, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 27, 2018

Indexes:

Not included

Description:

GT Biopharma is a biotechnology company focused on developing innovative immunotherapies for cancer treatment. They create therapies that harness the body’s immune system to target and destroy cancer cells, aiming to improve patient outcomes and advance cancer care.

Events Calendar

Earnings

Next earnings date:

Mar 26, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 5, 2024

Analyst ratings

Recent major analysts updates

Dec 2, 24 Roth MKM
Buy
Aug 8, 23 HC Wainwright & Co.
Buy
Aug 7, 23 EF Hutton
Hold
Jun 5, 23 HC Wainwright & Co.
Buy
May 17, 23 HC Wainwright & Co.
Buy
May 16, 23 EF Hutton
Hold
Apr 3, 23 HC Wainwright & Co.
Buy
Mar 31, 23 EF Hutton
Hold
Jan 5, 23 EF Hutton
Hold
Sep 13, 22 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for GT Biopharma?
  • Does GT Biopharma pay dividends?
  • What sector is GT Biopharma in?
  • What industry is GT Biopharma in?
  • What country is GT Biopharma based in?
  • When did GT Biopharma go public?
  • Is GT Biopharma in the S&P 500?
  • Is GT Biopharma in the NASDAQ 100?
  • Is GT Biopharma in the Dow Jones?
  • When was GT Biopharma's last earnings report?
  • When does GT Biopharma report earnings?
  • Should I buy GT Biopharma stock now?

What is the ticker symbol for GT Biopharma?

The ticker symbol for GT Biopharma is NASDAQ:GTBP

Does GT Biopharma pay dividends?

No, GT Biopharma does not pay dividends

What sector is GT Biopharma in?

GT Biopharma is in the Healthcare sector

What industry is GT Biopharma in?

GT Biopharma is in the Biotechnology industry

What country is GT Biopharma based in?

GT Biopharma is headquartered in United States

When did GT Biopharma go public?

GT Biopharma's initial public offering (IPO) was on March 27, 2018

Is GT Biopharma in the S&P 500?

No, GT Biopharma is not included in the S&P 500 index

Is GT Biopharma in the NASDAQ 100?

No, GT Biopharma is not included in the NASDAQ 100 index

Is GT Biopharma in the Dow Jones?

No, GT Biopharma is not included in the Dow Jones index

When was GT Biopharma's last earnings report?

GT Biopharma's most recent earnings report was on Nov 14, 2024

When does GT Biopharma report earnings?

The next expected earnings date for GT Biopharma is Mar 26, 2025

Should I buy GT Biopharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions